| NCT07365241 | AbbVie | Small Cell Lung Cancer | 2026-04-14 | PHASE3 |
| NCT05636111 | M.D. Anderson Cancer Center|Jazz Pharmaceuticals | Ovarian Cancer | 2023-07-12 | PHASE1 |
| NCT04291937 | Jazz Pharmaceuticals | Small Cell Lung Cancer | | |
| NCT06228066 | National Cancer Institute (NCI) | Small Cell Carcinoma of the Bladder|High Grade Neuroendocrine Tumors of the Urinary Tract | 2024-06-13 | PHASE2 |
| NCT05042934 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Metastatic Ewing Sarcoma|Recurrent Ewing Sarcoma | 2021-09-15 | PHASE1|PHASE2 |
| NCT07141771 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | SCLC, Extensive Stage | 2025-12-31 | PHASE1|PHASE2 |
| NCT05876715 | ERLINDA M GORDON | Advanced Soft-tissue Sarcoma | 2023-06-07 | PHASE1|PHASE2 |
| NCT04802174 | National Cancer Institute (NCI) | SCLC|Small Cell Cancer|Advanced Solid Tumor|High Grade Neuroendocrine Cancers | 2021-06-01 | PHASE1|PHASE2 |
| NCT02210364 | PharmaMar | Metastatic Breast Cancer|Pancreatic Cancer|Metastatic Colorectal Cancer | 2013-04 | PHASE1 |
| NCT06217536 | University of California, San Francisco|Jazz Pharmaceuticals | Locally Advanced Soft Tissue Sarcoma | 2024-10-31 | PHASE1|PHASE2 |
| NCT05153239 | PharmaMar | Relapsed Small Cell Lung Cancer | 2022-07-22 | PHASE3 |
| NCT05918640 | Children´s Hospital of Philadelphia|Jazz Pharmaceuticals|Stand Up To Cancer | Ewing Sarcoma|Desmoplastic Small Round Cell Tumor|Pediatric Cancer|Undifferentiated Sarcoma | 2023-07-27 | PHASE1|PHASE2 |
| NCT02454972 | PharmaMar | Advanced Solid Tumors | 2015-08-25 | PHASE2 |
| NCT06501976 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Small Cell Lung Carcinoma | 2024-07 | PHASE2 |
| NCT05072106 | PharmaMar | Advanced Solid Tumor | 2021-01-14 | PHASE1 |
| NCT05244239 | Emory University|National Cancer Institute (NCI)|Jazz Pharmaceuticals | Extensive Stage Lung Small Cell Carcinoma|Stage IV Lung Cancer AJCC v8 | 2022-07-27 | PHASE1 |
| NCT01970553 | PharmaMar | Specific Advanced Solid Tumors | 2011-05 | PHASE1 |
| NCT05091567 | Hoffmann-La Roche|Jazz Pharmaceuticals | Small-Cell Lung Cancer | 2021-11-18 | PHASE3 |
| NCT02566993 | PharmaMar | Small-cell Lung Cancer | 2016-08-30 | PHASE3 |
| NCT04607954 | Mayo Clinic | Platinum-Resistant Lung Small Cell Carcinoma|Platinum-Sensitive Lung Small Cell Carcinoma|Recurrent Extensive Stage Lung Small Cell Carcinoma|Refractory Extensive Stage Lung Small Cell Carcinoma | 2020-12-04 | PHASE2 |
| NCT03213301 | Swiss Cancer Institute | Malignant Pleural Mesothelioma, Advanced | 2017-09-28 | PHASE2 |
| NCT06385548 | Vall d´Hebron Institute of Oncology | Endometrial Cancer | 2024-05 | PHASE1|PHASE2 |
| NCT05574504 | AdventHealth|Jazz Pharmaceuticals | Metastatic Cancer|Urothelial Carcinoma | 2023-05-08 | PHASE2 |
| NCT04358237 | Antonio Calles Blanco|MedSIR|PharmaMar|Merck Sharp & Dohme LLC | Small Cell Lung Carcinoma | 2020-09-21 | PHASE1|PHASE2 |
| NCT06203210 | Daiichi Sankyo|Merck Sharp & Dohme LLC | Small Cell Lung Cancer | 2024-05-21 | PHASE3 |
| NCT05063318 | PharmaMar | Advanced Solid Tumors | 2020-10-07 | PHASE1 |
| NCT01980667 | PharmaMar | Advanced Solid Tumors | 2014-07-30 | PHASE1 |
| NCT07121478 | National Cancer Center, Korea|Seoul National University Bundang Hospital|Samsung Medical Center|Seoul National Hospital|Gangnam Severance Hospital | Neuroendocrine Tumor of Pancreas|Pancreatic Neuroendocrine Tumors | 2025-09-23 | PHASE2 |
| NCT04610658 | H. Lee Moffitt Cancer Center and Research Institute|Bristol-Myers Squibb|Jazz Pharmaceuticals | Small-cell Lung Cancer|Relapsed Small Cell Lung Cancer|Recurrent Small Cell Lung Cancer | 2020-11-23 | PHASE1 |
| NCT06496048 | Luye Pharma Group Ltd. | Relapsed Small Cell Lung Cancer | 2024-09-14 | PHASE3 |
| NCT07153055 | Misty Shields|Jazz Pharmaceuticals | Small Cell Lung Cancer ( SCLC )|Transformed Small Cell Lung Cancer | 2026-05 | PHASE1|PHASE2 |
| NCT04638491 | Luye Pharma Group Ltd. | Advanced Solid Tumor | 2020-11-24 | PHASE1 |
| NCT01970540 | PharmaMar | Endometrial Adenocarcinomas|Neuroendocrine Tumors|Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy | 2011-05-25 | PHASE1 |
| NCT02611024 | PharmaMar | Advanced Solid Tumors|Glioblastoma|Soft Tissue Sarcoma (Excluding GIST)|Endometrial Carcinoma|Epithelial Ovarian Carcinoma|Mesothelioma|Gastroenteropancreatic Neuroendocrine Tumor|SCLC|Gastric Carcinoma|Pancreatic Adenocarcinoma|Colorectal Carcinoma|Neuroendocrine Tumors | 2016-05-06 | PHASE1|PHASE2 |
| NCT06681220 | VA Office of Research and Development | Relapsed Small Cell Lung Cancer|Recurrent Small Cell Lung Cancer | 2026-02-23 | PHASE1|PHASE2 |
| NCT07155174 | AbbVie | Small Cell Lung Cancer | 2025-11-25 | PHASE2 |
| NCT07459634 | Jazz Pharmaceuticals|Jazz Pharmaceuticals Ireland Limited | Extensive-stage Small-cell Lung Cancer | 2026-04-25 | PHASE2 |
| NCT06497530 | Guangzhou Institute of Respiratory Disease | Extensive-Stage Small Cell Lung Cancer | 2024-08 | PHASE2 |
| NCT02451007 | PharmaMar | Solid Tumors | 2015-08-12 | PHASE2 |
| NCT05578326 | UNC Lineberger Comprehensive Cancer Center|G1 Therapeutics, Inc. | Lung Cancer|Small-cell Lung Cancer | 2022-10-12 | PHASE2 |
| NCT05740566 | Amgen | Small Cell Lung Cancer (SCLC) | 2023-05-31 | PHASE3 |
| NCT02421588 | PharmaMar | Ovarian Cancer | 2015-05 | PHASE3 |
| NCT05285033 | Intergroupe Francophone de Cancerologie Thoracique|Groupe Francais De Pneumo-Cancerologie|PharmaMar | Small-cell Lung Cancer | 2022-04-01 | |
| NCT07328425 | Italian Sarcoma Group | Desmoplastic Small Round Cell Tumor | 2025-11-21 | PHASE2 |
| NCT05734066 | Jazz Pharmaceuticals|Jazz Pharmaceuticals Ireland Limited | Refractory Ewing Sarcoma|Relapsed Ewing Sarcoma|Ewing Sarcoma | 2023-05-23 | PHASE1|PHASE2 |
| NCT05101265 | PharmaMar | Advanced Solid Tumor|Hepatic Impairment | 2021-03-09 | PHASE1 |
| NCT05800587 | Fox Chase Cancer Center | Lung Cancer|Small-cell Lung Cancer|Non Small Cell Lung Cancer | 2023-02-22 | PHASE2 |
| NCT06088290 | PharmaMar | Leiomyosarcoma | 2023-09-21 | PHASE3 |
| NCT05099666 | Massachusetts General Hospital|Jazz Pharmaceuticals | Advanced Soft-tissue Sarcoma|Metastatic Soft-tissue Sarcoma|Advanced Leiomyosarcoma|Leiomyosarcoma Metastatic | 2022-02-04 | PHASE1|PHASE2 |
| NCT05126433 | Jazz Pharmaceuticals|Jazz Pharmaceuticals Ireland Limited | Advanced Solid Tumor|Metastatic Solid Tumor|Urothelial Cancer|Poorly Differentiated Neuroendocrine Carcinomas|Homologous Recombination Deficient-Positive Malignancies Agnostic | 2022-03-03 | PHASE2 |
| NCT06801834 | Gilead Sciences | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | 2025-04-04 | PHASE3 |
| NCT01831089 | PharmaMar | Breast Cancer|Ovarian Cancer|Gynecological Cancer|Head and Neck Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Non-squamous Cell Lung Cancer | 2013-09 | PHASE1 |
| NCT02448537 | Massachusetts General Hospital|Dana-Farber Cancer Institute|PharmaMar | Metastatic Sarcoma | 2015-08 | PHASE2 |
| NCT01405391 | PharmaMar | Major Advanced Solid Tumors Other Than Colorectal | 2011-11 | PHASE1 |
| NCT02684318 | Poveda, Andrés, M.D.|AstraZeneca|PharmaMar | Advanced Cancer|Ovarian Cancer|Endometrial Cancer|Breast Cancer | 2015-07 | PHASE1|PHASE2 |
| NCT01314599 | PharmaMar | Acute Leukemia | 2011-05 | PHASE1 |
| NCT00877474 | PharmaMar | ADVANCED SOLID TUMORS | 2009-03 | PHASE1 |
| NCT01525589 | PharmaMar | Breast Cancer | 2012-06-13 | PHASE2 |
| NCT04253145 | Fundacion Oncosur | Carcinoma, Small Cell Lung | 2019-12-13 | PHASE1|PHASE2 |